Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 3
Submit an article Journal homepage
1,579
Views
19
CrossRef citations to date
0
Altmetric
Review

Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis

Robyn Laubea Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia;b Department of Gastroenterology, Macquarie University Hospital, Sydney, AustraliaView further author information
,
Sudarshan Paramsothya Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia;b Department of Gastroenterology, Macquarie University Hospital, Sydney, Australia;c Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, AustraliaView further author information
&
Rupert W Leonga Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia;b Department of Gastroenterology, Macquarie University Hospital, Sydney, Australia;c Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, AustraliaCorrespondence[email protected]
View further author information
Pages 275-292 | Received 10 Dec 2020, Accepted 06 Jan 2021, Published online: 05 Feb 2021

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

JD. Chetwood, S. Gupta, K. Subramaniam, P. De Cruz, G. Moore, YK. An, SJ. Connor, M. Kermeen, S. Paramsothy & RW. Leong. (2023) Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature. Expert Opinion on Drug Safety 0:0, pages 1-8.
Read now
Nils Erik Gilhus. (2023) Treatment considerations in myasthenia gravis for the pregnant patient. Expert Review of Neurotherapeutics 23:2, pages 169-177.
Read now

Articles from other publishers (17)

Rishika Chugh, Millie D. LongYue Jiang, Kimberly N. WeaverDawn B. BeaulieuEllen J. ScherlUma Mahadevan. (2023) Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry. American Journal of Gastroenterology.
Crossref
Shubha Bhat, Benjamin Click & Miguel Regueiro. (2023) Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies. Inflammatory Bowel Diseases.
Crossref
Robyn Laube, Christian P Selinger, Cynthia H Seow, Britt Christensen, Emma Flanagan, Debra Kennedy, Reme Mountifield, Sean Seeho, Antonia Shand, Astrid-Jane Williams & Rupert W Leong. (2023) Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut 72:6, pages 1040-1053.
Crossref
E. V. Shrayner, A. I. Khavkin, M. S. Novikova, A. Yu. Tikunov, A. V. Chechushkov, R. A. Kharakhorin & N. V. Tikunova. (2023) Modern strategies and prospects for the treatment of ulcerative colitis. Experimental and Clinical Gastroenterology 1:1, pages 149-157.
Crossref
Line Riis Jølving, Jan Nielsen, Mette Louise Andersen, Sonia Friedman & Bente Mertz Nørgård. (2023) Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study. BMC Medicine 21:1.
Crossref
Yu. B. Uspenskaya, B. A. Nanaeva & V. A. Oleynik. (2023) Conservative treatment of inflammatory bowel diseases during pregnancy. Review of current safety and efficacy data. Koloproktologia 22:1, pages 147-159.
Crossref
Jumpei Saito, Kayoko Kaneko, Hiroyo Kawasaki, Takeshi Hayakawa, Naho Yakuwa, Tomo Suzuki, Haruhiko Sago, Akimasa Yamatani & Atsuko Murashima. (2022) Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum. Journal of Pharmaceutical Health Care and Sciences 8:1.
Crossref
Laura Lorena Castiblanco, María Jesús García de Yébenes, Jose María Martín Martín & Loreto Carmona. (2022) Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy. Rheumatology International 42:12, pages 2125-2133.
Crossref
Jeffery M Venner & Charles N Bernstein. (2022) Immunomodulators: still having a role?. Gastroenterology Report 10.
Crossref
Reezwana Chowdhury & Sunanda V Kane. (2022) Pregnancy and Crohn’s disease: concerns and assurance of medical therapy. Gastroenterology Report 10.
Crossref
Adi Lahat & Eyal Klang. (2022) US supreme court decision: the gastroenterological perspective. Therapeutic Advances in Gastroenterology 15, pages 175628482211169.
Crossref
Robyn Laube, Eleanor Liu, Ying Li, Rupert W. Leong, Jimmy Limdi & Christian Selinger. (2022) Gastroenterology team members’ knowledge and practices with fertility therapy for women with inflammatory bowel disease. Therapeutic Advances in Gastroenterology 15, pages 175628482210875.
Crossref
Robyn Laube, Yvonne TranSudarshan ParamsothyRupert W. Leong. (2021) Assisted Reproductive Technology in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 116:12, pages 2334-2344.
Crossref
Markus Schmidt, Maritta Kühnert, Bettina Kuschel, Sven Kehl & Ute Margaretha Schäfer-Graf. (2021) Care of Women with Chronic Inflammatory Bowel Disease (Chronic IBD) During Pregnancy. Geburtshilfe und Frauenheilkunde 81:12, pages 1348-1353.
Crossref
Rupsa C. Boelig, Kjersti M. Aagaard, Michelle P. Debbink & Alireza A. Shamshirsaz. (2021) Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential. American Journal of Obstetrics and Gynecology 225:6, pages B19-B31.
Crossref
Erick Sánchez-Salguero, Karina Corona-Cervantes, Hector Armando Guzmán-Aquino, María Fernanda de la Borbolla-Cruz, Víctor Contreras-Vargas, Alberto Piña-Escobedo, Jaime García-Mena & Leopoldo Santos-Argumedo. (2021) Maternal IgA2 Recognizes Similar Fractions of Colostrum and Fecal Neonatal Microbiota. Frontiers in Immunology 12.
Crossref
Robyn Laube, Sudarshan Paramsothy & Rupert W. Leong. (2021) Review of pregnancy in Crohn’s disease and ulcerative colitis. Therapeutic Advances in Gastroenterology 14, pages 175628482110162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.